Layer 2 3 Intratelencephalic Neurons In Fragile X Syndrome is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cortical IT neurons show dendritic abnormalities in FXS.
The molecular pathophysiology of Fragile X Syndrome (FXS) involves loss of FMRP function, leading to dysregulated protein synthesis and synaptic dysfunction.[@bear2005][@huber2007]
mGluR Signaling Dysregulation
FMRP normally represses mGluR-dependent protein synthesis
Without FMRP, mGluR signaling is exaggerated
Leads to enhanced long-term depression (LTD)
Synaptic spines show immature morphology
Synaptic Protein Synthesis
Local translation at dendritic spines is dysregulated
Actin cytoskeleton regulators are affected
NMDA receptor trafficking is altered
AMPA receptor internalization is increased
Ion Channel Dysfunction
Potassium channel expression altered
Sodium channel function modified
Calcium signaling dysregulated
HCN channel function impaired
Key Genes and Proteins
Signaling Pathways
mGluR Theory of Fragile X Syndrome
Synaptic Dysfunction Mechanisms
NMDA Receptor Signaling
AMPA Receptor Trafficking
Actin Cytoskeleton Regulation
Protein Synthesis Dysregulation
Dendritic Spine Abnormalities
Disease Associations
Fragile X Syndrome - Primary condition
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) - Adult-onset movement disorder
[Parkinson's Disease](/diseases/parkinsons-disease) Research on shared mechanisms
Therapeutic Implications
Current Approaches
mGluR5 antagonists (under investigation)
GABA agonists
Stimulants for hyperactivity
Anticonvulsants for seizures
Disease-Modifying Strategies
FMRP restoration therapies
Target-based drug development
Gene therapy approaches
Neuroprotective Approaches
Antioxidant supplementation
Mitochondrial support
Calcium homeostasis modulation
Emerging Therapies
Antisense oligonucleotides (ASOs)
CRISPR-based gene editing
Small molecule FMRP activators
Background
The study of Layer 2 3 Intratelencephalic Neurons In Fragile X Syndrome has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.